Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × sapanisertib × Clear all

NCT03097328 2024-04-29

Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Phase 2 Completed

39 enrolled 12 charts

Carcinoma, Renal Cell